Table 2.

Antimicrobial susceptibility of A. xylosoxidans LMG 1863^T, A. xylosoxidans CF2-b and A. insuavis CF4-b.

	A. xylosoxidans LMG 1863T			A. xylosoxidans CF2-b			A. insuavis CF4-b
Antibiotic (µg/mL)	MIC	MBC	MBEC	MIC	MBC	MBEC	MIC	MBC	MBEC
Piperacillin/tazobactam	1	8	1024	1	8	2048	1	2	2048
+ DNase I (200 µg/mL)	-	-	1024	-	-	2048	-	-	512
+ Subtilisin (200 µg/mL)	-	-	1024	-	-	2048	-	-	512
+ Alginate lyase (200 µg/mL)	-	-	1024	-	-	2048	-	-	2048
Ceftazidime	8	16	2048	8	8	2048	4	8	512
+ DNase I (200 µg/mL)	-	-	2048	-	-	2048	-	-	512
+ Subtilisin (200 µg/mL)	-	-	2048	-	-	2048	-	-	512
+ Alginate lyase (200 µg/mL)	-	-	2048	-	-	2048	-	-	512
Tobramycin	>256	1024	1024	48	128	1024	24	64	1024
+ DNase I (200 µg/mL)	-	-	1024	-	-	1024	-	-	1024
+ Subtilisin (200 µg/mL)	-	-	1024	-	-	1024	-	-	1024
+ Alginate lyase (200 µg/mL)	-	-	1024	-	-	1024	-	-	1024
Colistin	4	8	128	4	8	128	4	16	128
+ DNase I (200 µg/mL)	-	-	128	-	-	32	-	-	64
+ Subtilisin (200 µg/mL)	-	-	64	-	-	32	-	-	64
+ Alginate lyase (200 µg/mL)	-	-	128	-	-	128	-	-	128

-, not tested.